Twitter | Search | |
Aju Mathew
Cancer doctor, global health researcher, teacher. Director, Kerala Cancer Care. Part-time faculty @ Univ of Kentucky. Adjunct faculty @ Manipal University
4,597
Tweets
365
Following
1,031
Followers
Tweets
Aju Mathew 13h
This is called ‘generational gap’.
Reply Retweet Like
Aju Mathew Sep 16
Replying to @ajumathew_
Sadly, it’s a dying skill. Few days ago, I asked a neuro res to do a fundus exam. She suggested an opthal consult. In old school medicine in Kerala, my prof asked me to come in night and examine fundus of all inpatients in the ward (40+ pts).
Reply Retweet Like
Aju Mathew Sep 16
This is why it’s very important to be proficient in fundus exam in an undilated eye. I always encourage fellows to train in this skill by examining fundus for a lot of normal patients seen in clinic. Unless you see plenty, it’s hard to figure out what’s abnormal.
Reply Retweet Like
Aju Mathew Sep 16
Replying to @RogueRad
Hartals or bandhs.
Reply Retweet Like
Aju Mathew Sep 16
A worthwhile goal indeed.
Reply Retweet Like
Aju Mathew Sep 16
That’s a great perspective. could be a reason. Hope it isn’t ignorance.
Reply Retweet Like
Aju Mathew Sep 16
Ignorance or something else? I know a situation where osimertinib was recommended for EGFR wild type adeno lung, s/p nivolumab. Pt was in ICU on high suppl O2. He died a few days later.
Reply Retweet Like
Aju Mathew Sep 15
Sharing in your joy, Kusum and family.
Reply Retweet Like
Aju Mathew retweeted
Binay Shah, MD, MHA Sep 15
Completely agree with . This issue is so close to my heart- will discuss access to care @ where some of the most influential leaders are expected to join us
Reply Retweet Like
Aju Mathew Sep 15
Replying to @oncology_bg
TACTICS trial from Japan presented during ASCO GI cancer symposium 2018.
Reply Retweet Like
Aju Mathew retweeted
Akhila Reddy M.D. Sep 14
Dr. Rajagopal, 2018 Nobel Peace Prize Nominee receiving the John Mendelsohn Award for Outstanding Contributions in the Field of Palliative Care today ⁦⁩ from ⁦⁩ ⁦
Reply Retweet Like
Aju Mathew Sep 15
Replying to @oncology_bg
Introduced a new endpoint. :)
Reply Retweet Like
Aju Mathew Sep 15
Replying to @oncology_bg
That’s three negative trials out of four in this space. How did they make that one trial positive? See next tweet.
Reply Retweet Like
Aju Mathew retweeted
Mark A Febbraio Sep 14
The precise reason why we should NEVER evaluate track records by counting numbers. A Nobel Laureate I knew was once asked why he published so few papers...”I won the prize for Medicine not Literature “
Reply Retweet Like
Aju Mathew Sep 15
On Nehru & M Visvesvaraya: This is the sort of quality we miss in today’s leaders. Encouraging and respecting ideas that disagree with one’s own.
Reply Retweet Like
Aju Mathew Sep 15
Hope to catch up with a lot of friends during this summit in Seattle.
Reply Retweet Like
Aju Mathew Sep 15
Replying to @gabe_a_brooks
Must have been a mistake. Never seen that happen.
Reply Retweet Like
Aju Mathew retweeted
Dr. Jennifer McQuade Sep 13
We also still often spot Dr. Freireich in the halls of . Every time I do, I approach a patient he just walked past and say, “Do you know who that man is?” ...no “That man is a big reason why childhood leukemia went from uniformally fatal to >90% cure rate.”
Reply Retweet Like
Aju Mathew Sep 14
A quote that I agree 50%. Don’t forget to 😊 physician-scientists who you meet in that 🌉
Reply Retweet Like
Aju Mathew Sep 14
Excellent summary on immunotherapy ‘emerging’ biomarkers by
Reply Retweet Like